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For nearly two decades, synthetic chemists have been fascinated by the structural complexity 
and synthetic challenges afforded by the guanacastepene and heptemerone diterpenoids.
Numerous synthetic approaches to these compounds have been reported, but to date the 
application of enantioselective catalysis to this problem has not been realized. Herein we report 
an enantioselective synthesis of an advanced intermediate corresponding to the tricyclic core 
common to the guanacastepenes and heptemerones. Highlights of this work include sequential 
Pd-catalyzed decarboxylative allylic alkylation reactions to generate the two all carbon 
quaternary stereocenters, the use of ring-closing metathesis to close the A ring in the presence of 
a distal allyl sidechain, and a regio- and diastereoselective oxidation of an trienol ether to 
introduce oxygenation on the A ring. 
2009 Elsevier Ltd. All rights reserved.
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1. Introduction 
The guanacastepenes are a family of diterpenoids (Figure 1) 
originally isolated by Clardy and coworkers from an unidentified 
fungus that was found growing on a tree, Daphnopsis americana, 
in Costa Rica.1 Various members of the family have displayed 
interesting anticancer2 and antibacterial3 activity. In 2005, Sterner 
and co-workers reported the isolation of structurally similar 
diterpenoids, the heptemerones, from the mushroom Coprinus 
heptemerus.4 Structurally, the guanacastepenes and heptemerones 
are interesting due to their unusual 5-7-6 ring system with a 
highly oxidized upper portion and fully saturated lower half. Of 
particular note are the two quaternary carbon stereocenters that 
have proven to be the one of the biggest synthetic challenges 
posed by these targets. 
 
Figure 1. Representative members of the guanacastepene and 
heptemerone diterpenoids. 
Although initial excitement over this family of natural 
products has tempered, due to their hemolytic activity,5 the 
synthetic community continues to demonstrate interest in these 
molecules.6,7 While there have been several nonasymmetric and 
asymmetric total syntheses of these molecules, no catalytic 
enantioselective routes have been described in the literature. 
When our work on these targets started, our group had recently 
disclosed a series of asymmetric Pd-catalyzed decarboxylative 
allylic alkylation reactions capable of constructing all-carbon 
quaternary stereocenters with high levels of stereocontrol.8 At the 
same time, we had a burgeoning interest in deploying this 
technology in natural product synthesis,9 and believed these 
targets would be an ideal challenge for this newly developed 
technology. Herein, we describe our enantioselective synthesis of 
the tricyclic core common to the guanacastepenes and 
heptemerones.  
2. Results and Discussion 
2.1. Synthetic plan 
We planned to use keto-acetonide 1 (Scheme 1) as our initial 
synthetic target owing to Danishefsky and co-workers’ success in 
accessing (±)-guanacastepene A from this intermediate.10 The 
acetonide-protected diol would arise through reduction of the 
corresponding ketoester. We envisoned that the six-membered 
ring of 1 could be constructed through a Knoevenagel 
condensation, after chain elongation of the allyl moiety of 2, 
while the isopropyl-substituted cyclopentanone moiety would be 
constructed from the cyclopentene portion of 2. The α-quaternary 
stereocenter in 2 would be installed by a Pd-catalyzed 
decarboxylative allylic alkylation, while the five-membered ring 
could be closed by ring-closing metathesis (RCM) of 3. The 
styryl moiety in cycloheptenone 3 would be installed by 
performing Stork–Danheiser chemistry on vinylogous ester 4.11 
Ultimately, an asymmetric decarboxylative allylic alkylation of 
β-ketoester (±)-5 would serve as the source of asymmetry in our 
synthesis. 
Scheme 1.  
 
2.2. Installation of first stereocenter 
Reaction of 1,3-cycloheptanedione (6)12 with isobutanol under 
Dean–Stark conditions in the presence of PPTS produced 
vinylogous ester 7 (Scheme 2). Although vinylogous 
esterification proceeded smoothly, a significant amount of the 
retro-Dieckmann product was obtained if the generated water 
was not efficiently removed. This side product could be 
eliminated with two simple procedural modifications. First, the 
isobutanol should be distilled from CaO. Second, the heating 
bath should be preheated before addition of the reaction mixture. 
Acylation of 7 with allyl cyanoformate, and subsequent 
methylation, gave the required β-ketoester (±)-5. It should be 
noted at this point that the absolute configuration of the natural 
products requires the use of (R)-t-BuPHOX, which is derived 
from the unnatural enantiomer of tert-leucine. Consequently, 
much of the subsequent work was carried out with racemic 
material obtained by using PPh3 as the ligand. We also used the 
more readily available (S)-t-BuPHOX to demonstrate that the 
planned enantioselective decarboxylative allylic alkylation could 
proceed in good yield and acceptable enantioselectivity [(±)-
5→(S)-4].  
Scheme 2.  
 
Addition of β-lithiosytrene to vinylogous ester 4 afforded 
cyclohepteneone 3 (Scheme 2). In contrast to what is observed 
when performing Stork–Danheiser chemistry on six-membered 
rings, the intermediate β-hydroxy cycloheptanone was found to 
be particularly stable.13 Fortunately, warming with aqueous HCl 
was sufficient to push the elimination toward 3. Attempts were 
made to derivatize 3 (e.g. oxime, semicarbazone, various 
hydrazones) in order to affect enantioenrichment through 
recrystallization; unfortunately none were successful in forming 
suitably crystalline products. Fortunately, however, further 
transformations would make such enrichment unnecessary. 
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2.3. Installation of second stereocenter 
Ring-closing metathesis (RCM) with the second-generation 
Grubbs catalyst afforded bicyclic dieneone 8, which was acylated 
and methylated to give alkylation substrate 9. When screening 
ligands to promote the Pd-catalyzed alkylation reaction, we 
found that the use of an achiral phosphinooxazoline (PHOX) 
ligand or either antipode of t-BuPHOX resulted in the formation 
of a single diastereomer of 2 in all cases. Unfortunately, 
comparison with later synthetic intermediates revealed this to be 
the undesired syn-methyl diastereomer (syn-2).  
Scheme 3.  
 
Molecular modeling of the enolate intermediate derived from 
ketone 9 (enolate A) was performed in order to understand the 
high degree of diastereoselectivity observed in this reaction 
(Figure 2). This effort revealed that the methyl group of the 
previously installed quaternary stereocenter sits in a pseudoaxial 
position and effectively blocks the Re face of the enolate. This is 
in excellent agreement with related computational work by Houk 
that was reported after our experimental work was completed.14,15 
Houk’s work also revealed that steric effects, rather than 
torsional effects,16 were primarily responsible for the observed 
stereoselectivity.  
 
Figure 2. Calculated (B3LYP/6-31+G(d), SMDTHF) structure of 
enolate A.  
Clearly the large amount of substrate control imposed by 
enolate A would be difficult to overcome using a bicyclic 
scaffold. However, we believed diminished substrate control 
might be experienced with a monocyclic enolate.17 To test this 
hypothesis, ketone 3 was converted to β-ketoester 10 (Scheme 4). 
Subjecting ketoester 10 to Pd-catalyzed decarboxylative allylic 
alkylation, in the presence of an achiral PHOX ligand, afforded 
ketone 11 with a diastereomeric ratio of 2.6:1. Using either 
antipode of t-BuPHOX resulted in a dr of 1.3:1. It should be 
emphasized that these results were obtained using material 
derived from racemic ketone 3. This means that if we were to 
observe complete catalyst control, the best possible dr we could 
see with (S)- or (R)-t-BuPHOX is 1:1. With this in mind, the 
diastereoselectivity afforded by (S)- and (R)-t-BuPHOX was 
actually quite encouraging.18  
With this result in hand, ketone (R)-4, of 83% ee, was 
prepared using (R)-t-BuPHOX and advanced to β-ketoester 
(R,R/S)-10. Performing the second Pd-catalyzed allylic alkylation 
with (R)-t-BuPHOX furnished ketone (R,R)-11 with 9:1 
diastereoselectivity. Furthermore, the major diastereomer was 
formed with improved levels of enantiopurity (96% ee), in 
accordance with the Horeau principle.19 Because both 
stereocenters of 11 were formed through catalyst control using 
the same antipode of the ligand, we are confident that the major 
diastereomer has the desired anti-methyl relationship. 
Additionally, subsequent RCM furnished a bicyclic compound 
that was diastereometic to 2, vide infra. 
Scheme 4.  
 
2.4. Elaboration of the allyl group and Knoevenagel cyclization 
With the two quaternary stereocenters in place, our attention 
turned to completing the tricyclic ring system (Scheme 5). First, 
treating compound 11 with the second-generation Grubbs 
catalyst affected the closure of the A ring. Once the initial RCM 
reaction was complete, the indicated propenyl boronic ester20 was 
added to the reaction mixture in order to carry out a cross 
metathesis with the remaining allyl group. Undesired cross 
metathesis with the liberated styrene was minimized by carefully 
monitoring (TLC) the initial RCM. The resulting boronic ester 
(12) was not isolated. Instead it was immediately oxidized to 
aldehyde 13 with anhydrous21 Me3NO.22 A number of other cross 
metathesis partners were also examined, but none proved to be as 
useful or successful as the coupling with the vinyl boronate.  
Scheme 5.  
 
Re face blocked
enolate A
O
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Aldehyde 13 was then coupled to ethyl diazoacetate23 to 
furnish β-ketoester 14. To our delight, heating 14 with NaOEt 
affected the Knoevenagel cyclization10 needed to produce tricycle 
15 representing the complete guanacastepene ring skeleton. It 
should be noted the reactions presented in Scheme 3 were not 
optimized at this point. Nevertheless, they serve as a useful guide 
for how the tricyclic ring system can be constructed. 
2.5. Oxygenation of the A-ring. 
Having identified a serviceable route to the tricyclic ring 
system, we then concerned ourselves with oxidizing the 
cyclopentene ring. Considerable effort was expended on this 
particularly troublesome task. We investigated a number of 
conditions including regioselective epoxidations, 
dihydroxylations, and allyic oxidations, but all resulted in either 
no reaction or general decomposition of the starting material. Our 
prospects for carrying out this necessary transformation seemed 
bleak until we located a useful procedure from the literature. Kirk 
and Wiles found that α,β-unsaturated ketones could be converted 
into γ-hydroxylated ketones by utilizing a two-step procedure 
involving extended enol ether formation, followed by m-CPBA 
oxidation and hydrolysis.24,25,26 The authors found that solvent 
choice was critical to the regioselectivity, as use of CH2Cl2 or 
other anhydrous organic solvents resulted in oxidation at the α-
position. Conversely, the use of aqueous organic solvents (e.g. 
THF, dioxane, EtOH) along with slow addition of the oxidant 
provided the γ-hydroxy enone in good yields.24 
Applying these conditions to the present case proved to be 
particularly rewarding (Scheme 6). First, an RCM was used to 
convert anti-11 into anti-2. Careful monitoring of the reaction 
was needed in order to minimize competitive cross metathesis 
reactions (homodimer and styrene cross product) involving the 
allyl sidechain present in 2. Performing the reaction under an 
atmosphere of ethylene further minimized these pathways. 
Treating ketone 2 with TBSOTf furnished silyl enol ether 16. To 
our delight, oxidation of 16 with m-CPBA in 95% EtOH 
smoothly formed alcohol 17 in high yield and as the only 
observed isomer. Through experimentation it was found that 
magnesium monoperoxyphthalate (MMPP) performed better than 
m-CPBA in this oxidation. The secondary alcohol was then 
converted to TBS ether 18.  
Scheme 6.  
 
2.6. Multigram synthetic route 
Having finally succeeded in identifying conditions to 
oxygenate the cyclopentene ring, we then scaled up the route 
with enantioenriched material. Our final optimized route to 
compound 18 is shown in Scheme 7. Gratifyingly, many of the 
steps could be scaled with little problem, but there were a few 
last minute optimizations made along the way. The solvent of the 
initial decarboxylative allylic alkylation was changed from THF 
to toluene. This allowed for the relatively small increase in 
selectivity from 83% to 87% ee. Other notable details include the 
use of freshly prepared LHMDS for the acylation of 3 and using 
Cs2CO3, rather than NaH, for the subsequent methylation in order 
to improve the impurity profile of these particular 
transformations. 
The conversion of 4 to 3 was the one step that did need some 
more optimization. While the lithium-halogen exchange of β-
bromostyrene proceeded readily on small scale in THF, the large-
scale reaction proceeded to give products of phenylacetylene 
addition (e.g. deprotonation of α-hydrogen, elimination of 
bromide, deprotonation of phenylacetylene). Presumably, this 
was due to inefficient cooling of the exothermic lithium-halogen 
exchange reaction when performed in large volumes of THF. 
Changing the solvent to Et2O alleviated this problem. However, 
attempts to heat the mixture of Et2O with aqueous HCl to affect 
elimination of the hydroxyl group were unsuccessful, presumably 
due to the two-phase nature of the system. This could be 
overcome by first quenching the reaction with 10% HCl followed 
by removal of the volatiles under rotary evaporation. THF was 
then added and the mixture warmed to 50 ºC. By employing this 
procedure, 3 was formed in high yield on multigram scale. By 
following this 12-step route, and starting with 5.0 g of 
cycloheptanedione, we were able to synthesize 4.5 g of 18 as a 
pure, colorless oil.  
Scheme 7. 
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2.7. Generation of tricyclic core 
With multigram quantities of 18 in hand, we then had a 
difficult choice to make. Either we could take the time to 
elaborate the five membered ring into the required isopropyl-
containing cyclopentanone, or investigate that problem after 
forming the six-membered ring. For better or worse, we chose the 
latter.  
Starting with intermediate 18, a cross metathesis reaction was 
performed between the allyl group and the indicated vinyl 
boronate (Scheme 8). The resulting boronic ester was not 
isolated. Instead it was immediately oxidized to aldehyde 19 with 
anhydrous Me3NO. The aldehyde was then coupled to ethyl 
diazoacetate23 to furnish β-ketoester 20. Preliminary attempts at 
using an alkoxide base (NaOEt) to affect the desired 
Knoevenagel ring closure were successful,10 but we found that 
using KF as the base27 provided higher yields. Notably, the use of 
a protic solvent prevented cleavage of the TBS ether. Finally, 
stereoselective reduction of the β-ketoester, to give alcohol 22, 
was accomplished using a Noyori transfer hydrogenation.28 By 
relying on reagent control of the newly formed stereocenter, we 
were able to address the low diastereoselectivity (~4:1) observed 
by Danishefsky,10 Snider,29 and Wicha.7h Ester 22 was then 
converted into acetonide 23 using standard methods. 
Scheme 8.  
 
2.8. Attempts to functionalize the A ring 
With acetonide 23 in hand, we turned our attention to 
functionalizing the A ring (Scheme 9). We thought that the 
allylic ether already present in the A ring (A) contained enough 
functionality to allow for installation of the C12 isopropyl group 
(B). Following that, we planned to access the C14 ketone through 
isomerization of a C13-C14 epoxide (B→C→D). In this manner, 
and by starting with acetonide 23, we would generate the same 
intermediate ketone (1) used by Danishefsky and co-workers in 
their synthesis of guanacastepene A.10 This same intermediate 
would also be directly applicable to heptemerone G.7h 
 
 
Scheme 9.  
 
As the silyl ether at C12 was positioned on the α-face, we first 
considered using a Cu-catalyzed coupling reaction with i-
PrMgCl. Similar coupling reactions, albeit not as sterically 
crowded as the present example, have been shown to proceed 
with net inversion of the initial stereocenter.30,31 If successful, this 
would install the C12 isopropyl group with the correct relative 
configuration. Conversion of silyl ether 23 into allyl pivalate 24 
proceeded smoothly (Scheme 10), but all cross coupling attempts 
with this intermediate failed. This is likely due to the presence of 
the adjacent quaternary carbon. 
In an effort to relieve steric crowding, we decided to convert 
silyl ether 23 into a vinyl triflate. First, the silyl ether was cleaved 
using TBAF. The more sterically accessible alkene (A ring) was 
then hydrogenated under palladium catalysis. Oxidation with 
TPAP/NMO32 afforded cyclopentanone 25 in high yield for the 
sequence. Formation of the requisite vinyl triflate proceeded 
smoothly. To our delight, coupling between the vinyl triflate and 
i-PrMgCl proceeded to give triene 26 in high yield, using 
catalytic conditions reported by Bäckvall and co-workers.33  
Installing oxygenation on the A ring from compound 26, once 
again proved taxing. All attempts to isomerize the C12-C13 
double bond failed. Preliminary molecular modeling suggested 
that the tricyclic ring system adopted a twisted structure, which 
does not allow for efficient conjugation in the desired triene. 
Consequently, the trisubsubstituted A ring alkene is more 
thermodynamically favored. 
Scheme 10.  
 
In a final attempt to functionalize the A ring, we planned to 
employ a Grignard addition/oxidative transposition34,35 sequence 
(Scheme 11, box) in order to install the C12 isopropyl and C14 
ketone. Our prospects were bolstered by precedent from the 
Phillips36 and Mander37 labs, who performed an analogous 
transformation with cyclopentenones. This approach was 
evaluated by first converting silyl ether 18 into cyclopentenone 
27. Performing nOe experiments on compound 27 confirmed the 
site of A-ring oxidation. Treating ketone 27 with i-PrMgBr 
provided a product, whose 1H NMR spectrum was deficient by 
two alkene protons. This was tentatively assigned as conjugate 
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addition product 28. A similar result was obtained when the 
Grignard addition was performed in the presence of CeCl3.38 
After our work was completed, Wicha and co-workers 
successfully performed a similar 1,2-addition/oxidative 
transposition en route to the A ring of guacastepene.7h,39 Notably, 
their bicyclic intermediate contained a trans ring fusion between 
the A and B rings. This likely enforces a different conformation 
that provides a more open approach to the C12 ketone.  
Scheme 11.  
 
3. Conclusion 
We have developed the first catalytic enantioselective route to 
the tricyclic core common to the guanacastepene and 
heptemerone diterpenoids. Our route relies on sequential Pd-
catalyzed decarboxylative allylic alkylation reactions to generate 
the two all carbon quaternary stereocenters with high fidelity. We 
have also identified conditions through which oxygenation and 
the C12 isopropyl group can be introduced to the A ring. 
Although there is still work to be done, particularly on the A ring, 
the advanced intermediates we have generated may yet prove 
useful; especially when one considers the potential utility of 
biocatalysis as a means to perform regioselective C–H oxidation 
reactions.40 
4. Experimental section 
Unless otherwise stated, reactions were performed in flame-
dried glassware under an Ar or N2 atmosphere using dry, 
deoxygenated solvents. Solvents were dried by passage through 
an activated alumina column under argon. Triethylamine, 
pyridine, and diisopropylamine were distilled from calcium 
hydride immediately prior to use. Isobutanol was distilled from 
CaO prior to use. β-bromostyrene was distilled (110 ºC, 20 
mmHg) and storred under Ar in a Schlenk flask. Allyl 
cyanoformate,41 TBSOTf,42 and Ru[(S,S)-Ts-DPEN](p-
cymene)28a were prepared by known methods. (S)- and (R)-t-Bu-
PHOX was prepared by known methods.43 (R)-t-Leucinol was 
resolved using a known procedure.44 Reaction temperatures were 
controlled by an IKAmag temperature modulator. Thin-layer 
chromatography (TLC) was performed using E. Merck silica gel 
60 F254 precoated plates (0.25 mm) and visualized by UV 
fluorescence quenching, anisaldehyde, or KMnO4 staining. ICN 
Silica gel (particle size 0.032-0.063 mm) was used for flash 
chromatography. Analytical chiral HPLC was performed with an 
Agilent 1100 Series HPLC utilizing chiralcel AD, OD-H, or OJ 
columns (4.6 mm x 25 cm) obtained from Daicel Chemical 
Industries, Ltd with visualization at 254 nm. Analytical achiral 
GC was performed with an Agilent 6850 GC utilizing a DB-
WAX (30m x 0.25 mm) column (1.0 mL/min carrier gas flow). 
Optical rotations were measured with a Jasco P-1010 polarimeter 
at 589 nm. 1H and 13C NMR spectra were recorded on a Varian 
Mercury 300 (at 300 MHz and 75 MHz respectively) or Varian 
Unity Inova 500 (at 500 MHz and 125 MHz respectively), and 
are reported relative to CDCl3/CHCl3 (1H NMR δ 7.26, 13C NMR 
δ 77.0). Data for 1H NMR spectra are reported as follows: 
chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). The following abbreviations are used to report NMR 
data: s = singlet, d = doublet, t = triplet, q = quartet, sept = septet, 
br = broad, obsc = obscured, app = apparent. IR spectra were 
recorded on a Perkin Elmer Paragon 1000 spectrometer and are 
reported in frequency of absorption (cm-1). High resolution mass 
spectra were obtained from the Caltech Mass Spectral Facility. 
4.1. 3-Isobutoxycyclohept-2-enone (7) 
A 250 mL round-bottom flask fixed with a Dean–Stark trap was 
charged with 1,3-cycloheptanedione (6, 5.0054 g, 39.7 mmol) 
and toluene (40 mL). Isobutanol (30 mL, 325 mmol, 8.2 equiv) 
and PPTS (149.6 mg, 0.595 mmol, 1.5 mol%) were added and 
the mixture was then placed in an oil bath pre-heated to 130 °C. 
After two hours TLC indicated complete consumption of starting 
material. The reaction was cooled and concentrated in vacuo. The 
residue was then distilled at 0.6 mmHg, collecting the portion 
that distilled at 91–96 °C, to afford the title compound (5.3025 g, 
73% yield) as a yellow oil. RF = 0.06 (10:1 Hexane:EtOAc); 1H 
NMR (500 MHz, CDCl3) δ5.37 (s, 1H), 3.49 (d, J = 6.6 Hz, 
2H), 2.60-2.56 (m, 4H), 2.00 (app sept, J = 6.6 Hz, 1H), 1.88-
1.77 (m, 4H), 0.96 (d, J = 6.8 Hz, 6H); 13C NMR (125 MHz, 
CDCl3) δ 202.5, 176.6, 106.0, 75.0, 41.9, 33.1, 27.9, 23.7, 21.5, 
19.3; IR (Neat Film NaCl) 2958, 2872, 1646, 1607, 1469, 1237, 
1190, 1174 cm-1; HRMS (EI) m/z calc'd for C11H18O2 [M]+•: 
182.1307; found 182.1310. 
4.2. Allyl 4-isobutoxy-1-methyl-2-oxocyclohept-3-enecarboxylate 
(5) 
n-Butyllithium (2.12 M in hexane, 15 mL, 31.8 mmol) was added 
to a solution of N,N-diisopropylamine (4.4 mL, 31.4 mmol) in 
100 mL THF at –78 °C and the solution stirred for 30 min. A 
solution of 3-isobutoxycyclohept-2-enone (7, 4.9996 g, 27.43 
mmol) in 10 mL THF was added via cannula with a 5 mL THF 
rinse. After stirring for 30 min, allyl cyanoformate (3.3677 g, 
30.3 mmol) was added. The reaction was kept at –78 °C for 3 
hours and then quenched with 50 mL of half saturated aq. NH4Cl 
and allowed to thaw. The mixture was diluted with 50 mL Et2O 
and the aqueous layer washed 3 x 50 mL Et2O. The combined 
organic layers were washed sequentially with water and brine, 
dried over MgSO4, and evaporated in vacuo. The residue was 
then dissolved in 60 mL THF and cooled to 0 °C. NaH (60% 
dispersion in mineral oil, 1.2218 g, 30.5 mmol) was added in 
portions over 10 min. The mixture was stirred cold 20 min, and 
then MeI (5 mL, 80.3 mmol) was added. The reaction was then 
heated to 50 °C for 1 hour. The reaction was then quenched by 
the careful addition of 50 mL of half saturated aq. NH4Cl. The 
mixture was diluted with 50 mL Et2O and the aqueous layer 
washed 3 x 25 mL Et2O. The combined organic layers were 
washed with brine, dried over MgSO4, and evaporated in vacuo. 
Silica gel chromatography (5 x 21 cm, 10:1 hexanes:EtOAc) 
afforded the title compound as a pale yellow oil (5.9924 g, 78% 
yield). RF = 0.20 (10:1 Hexane:EtOAc); 1H NMR (300 MHz, 
CDCl3) δ 5.86 (dddd, J = 5.4, 5.4, 10.5, 16.8 Hz, 1H), 5.40 (s, 
1H), 5.29 (dddd, J = 1.5, 1.5, 1.5, 17.1 Hz, 1H), 5.20 (dddd, J = 
1.2, 1.2, 1.2, 10.5 Hz, 1H), 4.63 (dddd, J = 1.2, 1.2, 5.7, 13.2 Hz, 
1H), 4.56 (dddd, J = 1.2, 1.2, 5.1, 12.9 Hz, 1H), 3.51 (dd, J = 6.6, 
9.6 Hz, 1H), 3.46 (dd, J = 6.6, 9.3 Hz, 1H), 2.59 (ddd, J = 4.2, 
9.3, 18 Hz, 1H), 2.47-2.36 (m, 2H), 2.04-1.92 (obsc m, 1H), 1.98 
(app sept, J = 6.8 Hz, 1H), 1.81 (ddd, J = 4.2, 9.3, 18.9 Hz, 1H), 
1.70 (ddd, 4.5, 7.5, 14.4 Hz, 1H), 1.43 (s, 3H), 0.95 (app d, J = 
6.6 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 198.8, 173.7, 173.3, 
131.7, 118.2, 104.9, 74.6, 65.5, 58.8, 34.1, 33.7, 27.7, 24.0, 21.1, 
19.0; IR (Neat Film NaCl) 3084, 2959, 2935, 1733, 1652, 1612, 
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1456, 1383, 1233, 1197, 1170, 1114, 994 cm-1; HRMS (EI) m/z 
calc'd for C16H24O4 [M]+•: 280.1675; found 280.1686. 
4.3.  (R)-7-Allyl-3-isobutoxy-7-methylcyclohept-2-enone ((R)-4) 
In a nitrogen filled glove box, a flask was charged with Pd(dm-
dba)2 (568.4 mg, 0.697 mmol, 2 mol%), (R)-tBu-PHOX (334.8 
mg, 0.864 mmol, 2.5 mol%), and 200 mL toluene. The mixture 
was stirred 30 min, at which time allyl 4-isobutoxy-1-methyl-2-
oxocyclohept-3-enecarboxylate (5, 9.8032 g, 34.97 mmol) was 
added with a total of 150 mL toluene. The reaction was then 
taken out of the govebox, placed under a stream of argon, and 
stirred 60 hrs. The mixture was then evaporated in vacuo. Silica 
gel chromatography (5 x 18 cm, 25:1 hexanes:EtOAc) afforded 
the title compound as a colorless oil (7.8401 g, 95% yield). RF = 
0.36 (10:1 Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 5.72 
(dddd, J = 7.2, 7.2, 10.8, 15.9 Hz, 1H), 5.31 (s, 1H), 5.05 (br s, 
1H), 5.01 (dddd, J = 1.5, 1.5, 2.7, 5.1 Hz, 1H), 3.51 (dd, J = 6.6, 
9.3 Hz, 1H), 3.45 (dd, J = 6.6, 9.3 Hz, 1H), 2.50-2.45 (m, 2H), 
2.38 (app dd, J = 7.2, 13.5 Hz, 1H), 2.20 (dddd, J = 1.2, 1.2, 7.5, 
8.7 Hz, 1H), 1.98 (app sept, J = 6.6 Hz, 1H), 1.89-1.70 (m, 3H), 
1.63-1.55 (m, 1H), 1.14 (s, 3H), 0.95 (app d, J = 6.9 Hz, 6H); 13C 
NMR (75 MHz, CDCl3) δ 206.5, 171.1, 134.4, 117.7, 104.8, 
74.3, 51.3, 45.2, 35.9, 35.0, 27.8, 25.0, 19.7, 19.1; IR (Neat Film 
NaCl) 3075, 2959, 2932, 1614, 1470, 1387, 1213, 1192, 1172, 
998, 912 cm-1; HRMS m/z calc'd for C15H24O2 [M]+: 236.1776, 
found 236.1775; [α]D24.9 +61.39 (c 1.055, CH2Cl2, 87% ee). 
4.4.  (R)-4-Allyl-4-methyl-3-styrylcyclohept-2-enone ((R)-3) 
β-Bromostyrene (7 mL, 54.57 mmol) was dissolved in 64 mL 
Et2O and cooled to –78 °C. t-BuLi (1.6 M in pentane, 64 mL, 
102.4 mmol) was added over 40 min. The mixture was stirred at 
–78 °C for 1 hr, at which time (R)-7-allyl-3-isobutoxy-7-
methylcyclohept-2-enone (4, 7.8335 g, 33.14 mmol) in 15 mL 
Et2O was added by cannula with a 5 mL rinse. After 90 min, the 
reaction was warmed with an ice bath and stirred for 1 hr. The 
reaction was quenched with 10% HCl (100 mL), and the volatiles 
removed in vacuo. To the residue was added 100 mL THF. The 
mixture was then heated to 50 °C for 12 hrs. After cooling to 
room temperature, the mixture was extracted 4 x 100 mL Et2O. 
The combined organic extracts were dried over MgSO4, and 
evaporated in vacuo. Silica gel chromatography (5 x 17 cm, ~700 
mL 20:1 hexanes:EtOAc then ~1.6 L 15:1 hexanes:EtOAc) 
afforded the title compound as a viscous yellow oil (8.0542 g, 
91% yield). RF = 0.23 (10:1 Hexane:EtOAc); 1H NMR (300 
MHz, CDCl3) δ 7.45-7.27 (m, 5H), 6.90 (s, 2H), 6.31 (s, 1H), 
5.68 (dddd, J = 6.6, 8.1, 10.5, 17.1 Hz, 1H), 5.09-5.01 (m, 2H), 
2.66-2.61 (m, 2H), 2.47 (dd, J = 6.6, 14.1 Hz, 1H), 2.14 (dd, J = 
8.1, 14.1 Hz, 1H), 1.93-1.80 (m, 3H), 1.70-1.60 (m, 1H), 1.27 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 204.5, 158.3, 136.5, 133.7, 
133.1, 129.0, 128.7, 128.3, 126.9, 126.9, 118.3, 46.0, 44.3, 44.2, 
38.5, 26.6, 17.4; IR (Neat Film NaCl) 3075, 3026, 2925, 1640, 
1582, 1450, 1344, 1250, 1217, 963, 916, 752, 694 cm-1; HRMS 
m/z calc'd for C19H22O [M]+: 266.1671, found 266.1668; [α]D24.8 
+33.70 (c 1.19, CHCl3, 88% ee). 
4.5.  (±)-8a-methyl-6,7,8,8a-tetrahydroazulen-5(1H)-one (8) 
To a solution of (±)-4-allyl-4-methyl-3-styrylcyclohept-2-enone 
(3, 634.g mg, 2.38 mmol) in 80 mL degassed (argon bubbling) 
CH2Cl2 was added the second generation Grubbs catalyst (5.2 
mg, 0.00612 mmol, 0.25 mol%). The mixture was then heated to 
50 ºC for 50 min and then cooled to ambient temperature. Ethyl 
vinyl ether (5 mL) was added and the mixture stirred 30 min. 
Evaporation in vacuo, followed by silica gel chromatography (2 
cm x 16 cm, 15:1 hexane:EtOAc) afforded the title compound as 
a colorless oil (351.3 mg, 91% yield). RF = 0.17 (10:1 
Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 6.34 (ddd, J = 
0.6, 3, 5.4 Hz, 1H), 6.14 (ddd, 1.5, 2.1, 5.4 Hz, 1H), 5.87 (s, 1H), 
2.71 (ddddd, J = 0.9, 0.9, 3.6, 6.3, 15 Hz, 1H), 2.59-2.49 (m, 2H), 
2.41 (ddd, J = 1.5, 2.7, 18 Hz, 1H), 2.14-1.80 (m, 4H), 1.23 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 204.6, 169.0, 142.6, 134.2, 
121.5, 51.4, 46.5, 44.9, 37.7, 29.5, 21.0; IR (Neat Film NaCl) 
3059, 2930, 1650, 1615, 1449, 1352, 1261, 968 cm-1; HRMS m/z 
calc'd for C11H14O [M]+: 162.1045, found 162.1040. 
4.6.  (±)-(6R,8aR)-6-Allyl-6,8a-dimethyl-6,7,8,8a-
tetrahydroazulen-5(1H)-one (syn-2) 
To s solution of (±)-8a-methyl-6,7,8,8a-tetrahydroazulen-5(1H)-
one (8, 132.9 mg, 0.819 mmol) in 5 mL THF cooled to –78 °C 
was added a solution of LHMDS (1.0M in THF, 0.9 mL, 0.9 
mmol). The mixture was stirred 30 min and then allyl 
cyanoformate (106 mg, 0.954 mmol) was added. After 30 min, 8 
mL 50% sat. NH4Cl was added and the mixture allowed to warm 
to ambient temperature. The aqueous layer was extracted with 3 x 
10 mL Et2O, and the combined organic layers dried with MgSO4 
and evaporated in vacuo. The crude residue was then dissolved in 
5 mL THF and cooled to 0 °C. NaH (60% dispersion in mineral 
oil, 34.8 mg, 0.87 mmol) was added and the mixture stirred 10 
min. MeI (140 L, 2.25 mmol) was added and the reaction 
warmed to ambient temperature. After 1 hour, the reaction was 
quenched by the careful addition of ~5 mL 10% HCl. The 
mixture was then diluted with 10 mL H2O and 10 mL Et2O. The 
aqueous layer was awashed 3 x 10 mL Et2O. The combined 
organic layers were dried with MgSO4 and evaporated in vacuo. 
Flash chromatography (2 x 14 cm, 10:1 Hex/EtOAc) afforded β-
ketoester 9 (213.3 mg, 74% yield, 1 diastereomer) as a yellow 
oil. RF = 0.36 (5:1 Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) 
δ 6.38 (ddd, J = 2.7, 2.7, 5.4 Hz, 1H), 6.15-6.10 (m, 1H), 5.95 
(dddd, J = 5.4, 5.4, 10.8, 16.8 Hz, 1H), 5.76 (s, 1H), 5.34 (dddd, 
J = 1.5, 1.5, 1.5, 17.4 Hz, 1H), 5.22 (dddd, J = 1.5, 1.5, 1.5, 10.5 
Hz, 1H), 4.74-4.62 (m, 2H), 2.81 (ddd, J = 2.7, 14.7, 14.7 Hz, 
1H), 2.55 (bd, J = 18 Hz, 1H), 2.41 (ddd, J = 1.5, 3, 18 Hz, 1H), 
2.11 (ddd, J = 2.1, 14.1, 14.1 Hz, 1H), 1.81 (ddd, J = 2.7, 6, 14.7 
Hz, 1H), 1.70 (ddd, J = 1.8, 5.7, 14.4 Hz, 1H), 1.48 (s, 3H), 1.25 
(s, 3H). 
A flame-dried vial was charged with Pd(dm-dba)2 (4.5 mg, 
0.0.00552 mmol, 5 mol%), (S)-tBu-PHOX (2.5 mg, 0.00645 
mmol, 5.8 mol%), and 3 mL THF. The mixture is stirred at 25 °C 
for 30 min at which time β-ketoester 9 (29 mg, 0.111 mmol) 
prepared above was added by syringe. The reaction was stirred at 
25 °C for 5.5 hrs. Evaporation in vacuo followed by silica gel 
chromatography (3 x 3 cm, 20:1 hexanes:EtOAc) afforded the 
title compound as a light yellow oil (20.8 mg, 86% yield, >10:1 
mixture of diastereomers). RF = 0.40 (10:1 Hexane:EtOAc); 1H 
NMR (300 MHz, CDCl3) Major diastereomer: δ 6.26 (ddd, J = 
3, 3, 5 Hz, 1H), 6.09 (ddd, J = 1.8, 1.8, 5.4 Hz, 1H), 5.71 (s, 1H), 
5.61 (dddd, J = 6.9, 7.5, 10.2, 18 Hz, 1H), 5.06-4.97 (m, 2H), 
2.55-2.41 (m, 2H), 2.35 (ddd, J = 1.8, 2.7, 18 Hz, 1H), 2.26-1.93 
(m, 3H), 1.70 (app d, J = 5.1 Hz, 1H), 1.64 (app d, J = 5.7 Hz, 
1H), 1.12 (s, 3H), 1.07 (s, 3H); Diagnostic peaks of minor 
diastereomer: δ 5.74 (s), 1.15 (s), 1.11 (s); 13C NMR (75 MHz, 
CDCl3)  208.9, 164.5, 141.4, 133.6, 133.3, 119.5, 118.0, 50.9, 
50.7, 45.2, 42.2, 34.1, 33.2, 28.8, 23.4; IR (Neat Film NaCl) 
3075, 3059, 2961, 2929, 1656, 1625, 1450, 1375, 1220, 1204, 
1122, 913 cm-1. 
4.7.  (5R)-Allyl 5-allyl-1,5-dimethyl-2-oxo-4-styrylcyclohept-3-
enecarboxylate (10) 
To a solution of hexamethyldisilazane (10 mL, 47.71 mmol) in 
155 mL THF at –78 °C, was added n-butyllithium (2.4 M in 
hexane, 19 mL, 45.6 mmol) over 5 min. The mixture was stirred 
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30 min and then (R)-4-allyl-4-methyl-3-styrylcyclohept-2-enone 
(3, 8.0542 g, 30.24 mmol) in 15 mL THF (precooled to –78 °C) 
was added via cannula with a 5 mL rinse. After 30 min, allyl 
cyanoformate (4.4772 g, 40.30 mmol) was added quickly. After 
10 min, 100 mL of half saturated aq. NH4Cl was added to the 
cold reaction. The layers were separated and the aqueous layer 
washed with 3 x 100 mL EtOAc. The combined organic layers 
were dried with MgSO4 and evaporated in vacuo. The residue 
was then dissolved in 60 mL CH3CN, and Cs2CO3 (14.68 g, 
45.06 mmol) and MeI (10 mL, 160.28 mmol) were added. The 
mixture was then heated to 80 °C. After 4 hrs and 20 min the 
reaction was cooled to room temperature and filtered through a 
plug of silica gel (5 x 1 cm) which was then rinsed with 3 x 50 
mL EtOAc. The filtrate was then evaporated in vacuo. Silica gel 
chromatography (5 x 17 cm, 20:1 hexanes:EtOAc) afforded the 
title compound as an orange-yellow oil (9.9142 g, 90% yield). 1H 
NMR indicated an ~ 3:1 mixture of diasteromers. RF = 0.26 (10:1 
Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) Major 
diastereomer: δ 7.44-7.41 (m, 2H), 7.37-7.33 (m, 2H), 7.30-7.26 
(m, 1H), 6.91 (d, J = 15.5 Hz, 1H), 6.85 (d, J = 15.5 Hz, 1H), 
6.28 (s, 1H), 5.90 (dddd, J = 5.5, 5.5, 11, 22.5 Hz, 1H), 5.68 
(dddd, J = 7.5, 7.5, 10.5, 17.5 Hz, 1H), 5.33 (dddd, J = 1.5, 1.5, 
1.5, 17.5 Hz, 1H), 5.26-5.21 (m, 1H), 5.09-5.03 (m, 2H), 4.70-
4.56 (m, 2H), 2.44 (dd, J = 7.5, 14.5 Hz, 1H), 2.24 (app dd, J = 
8.5, 15 Hz, 1H), 2.18-2.13 (m, 2H), 1.80 (dd, J = 9.5 14 Hz, 1H), 
1.54 (dd, J = 8.5 Hz, 15 Hz, 1H), 1.44 (s, 3H), 1.23 (s, 3H), 
Minor diastereomer: δ 7.44-7.41 (m, 2H), 7.37-7.33 (m, 2H), 
7.30-7.26 (m, 1H), 6.89 (d, J = 16 Hz, 1H), 6.82 (d, J = 15.5 Hz, 
1H), 6.31 (s, 1H), 5.89 (dddd, J = 5.5, 5.5, 11.5, 22.5 Hz, 1H), 
5.61 (dddd, J = 7, 8.5, 10.5, 17 Hz, 1H), 5.31 (J = 1.5, 1.5, 1.5, 
17 Hz, 1H), 5.26-5.21 (m, 1H), 5.06-4.99 (m, 2H), 4.70-4.56 (m, 
2H), 2.41-2.34 (obsc m, 1H), 2.11 (obsc dd, J = 8, 14 Hz, 1H), 
1.79 (obsc ddd, 2H), 1.66 (ddd, J = 1, 9, 10 Hz, 2H), 1.47 (s, 3H), 
1.26 (s, 3H); 13C NMR (125 MHz, CDCl3) Major diastereomer: 
δ 202.6, 173.1, 156.9, 136.5, 133.5, 133.3, 131.8, 128.7, 128.4, 
128.1, 126.9, 124.6, 118.4, 118.0, 65.6, 60.2, 44.9, 44.5, 34.5, 
29.3, 26.3, 23.4, Minor diastereomer: δ 202.2, 172.8, 154.9, 
136.5, 133.4, 133.1, 131.7, 128.7, 128.3, 128.0, 126.8, 125,2, 
118.4, 118.2, 65.7, 59.8, 46.1, 44.3, 34.1, 28.9, 25.5, 21.8, ; IR 
(Neat Film NaCl) 3078, 3025, 2974, 2934, 1735, 1653, 1648, 
1584, 1448, 1375, 1221, 1196, 1103, 965, 918 cm-1; FAB+ 
HRMS m/z calc'd for C24H29O3 [M+H]+: 365.2117, found 
365.2117. 
4.8. (4R,7R)-4,7-Diallyl-4,7-dimethyl-3-styrylcyclohept-2-enone 
(anti-11) 
In a nitrogen filled glove box, a flask was charged with Pd(dm-
dba)2 (440.2 mg, 0.540 mmol, 2 mol%) and (R)-tBu-PHOX 
(253.0 mg, 0.653 mmol, 2.4 mol%) and 2500 mL THF. The 
mixture is stirred 30 min, at which time (5R)-allyl 5-allyl-1,5-
dimethyl-2-oxo-4-styrylcyclohept-3-enecarboxylate (10, 9.9052 
g, 27.18 mmol) was added with a total of 50 mL THF. The 
reaction was taken out of the glovebox and stirred at 25 °C for 24 
hrs. Evaporation in vacuo followed by silica gel chromatography 
(5 x 17 cm, 25:1 hexanes:EtOAc) afforded the title compound as 
a light yellow oil (8.163 g, 94% yield, 10:1 mixture of 
diastereomers). RF = 0.52 (10:1 Hexane:EtOAc); 1H NMR (300 
MHz, CDCl3) Major diastereomer: δ 7.45-7.27 (m, 5H), 6.90 
(d, J = 15.3 Hz, 1H), 6.82 (d, J = 15.6 Hz, 1H), 6.19 (s, 1H), 
5.79-5.54 (m, 2H), 5.08-4.97 (m, 4H), 2.34 (app dd, J = 6.3, 14.1 
Hz, 1H), 2.24 (app dd, J = 6.9, 12.9 Hz, 1H), 2.16 (app dd, J = 
8.1, 14.1 Hz, 1H), 2.08 (app dd, J = 8.1, 13.8 Hz, 1H), 1.93-1.84 
(m, 1H), 1.75-1.66 (m, 1H), 1.56-1.45 (m, 2H), 1.25 (s, 3H), 1.16 
(s, 3H); Diagnostic peaks of minor diastereomer: δ 6.20 (s), 
1.20 (s), 1.11 (s); 13C NMR (75 MHz, CDCl3)  209.4, 154.8, 
136.7, 133.7, 133.7, 132.8, 128.7, 128.3, 128.2, 126.8, 125.2, 
118.1, 118.0, 52.9, 46.2, 45.3, 44.4, 34.3, 29.8, 25.6, 22.8; IR 
(Neat Film NaCl) 3076, 3027, 2967, 2931, 1659, 1587, 1449, 
1373, 1194, 1147, 1120, 962, 915, 753, 694 cm-1; FAB+ HRMS 
m/z calc'd for C23H29O [M+H]+: 321.2218, found 321.2225; 
[α]D24.6 +87.18 (c 1.27, CHCl3, 10:1 dr, anti-Me diastereomer 
97% ee). 
4.9. (6R,8aR)-6-Allyl-6,8a-dimethyl-6,7,8,8a-tetrahydroazulen-
5(1H)-one (anti-2) 
A 3000 mL flask was charged with (4R,7R)-4,7-diallyl-4,7-
dimethyl-3-styrylcyclohept-2-enone (11, 8.1630 g, 25.47 mmol) 
and 2000 mL CH2Cl2. Argon was bubbled through the solution 
using a glass gas dispersion tube for 20 min, at which time 
ethylene was bubbled through the mixture for 5 min. The second 
generation Grubbs catalyst (434.1 mg, 0.511 mmol, 2 mol%) was 
added and ethylene was bubbled through the mixture for 15 min, 
followed by flushing the headspace for 15 min. The flask was 
then sealed. After 17 hrs, a second portion of the second 
generation Grubbs catalyst (112.7 mg, 0.133 mmol, 0.5 mol%) 
was added. After 3 hrs, the reaction was quenched by adding 90 
mL ethyl vinyl ether and allowed to stir 1.5 hrs. Evaporation in 
vacuo, followed by silica gel chromatography (5 cm x 17 cm, 4% 
Et2O in hexane) afforded the title compound as a yellow oil 
(5.3386 g, 89% yield with 6% starting material). RF = 0.40 (10:1 
Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) Major 
diastereomer: δ 6.28 (ddd, J = 3, 3, 5 Hz, 1H), 6.10-6.08 (m, 
1H), 5.83 (dddd, J = 6.5, 7.5, 11, 16 Hz, 1H), 5.73 (s, 1H), 5.06-
5.04 (m, 1H), 5.04-5.00 (m, 1H), 2.53-2.46 (m, 2H), 2.35 (ddd, J 
= 1.5, 3, 18 Hz, 1H), 2.15 (app dd, J = 8, 13.5 Hz, 1H), 2.13-2.06 
(m, 2H), 1.76-1.67 (m, 1H), 1.55-1.47 (m, 1H), 1.15 (s, 3H), 1.11 
(s, 3H); Diagnostic peaks of minor diastereomer: δ 5.71 (s), 
1.12 (s), 1.07 (s); 13C NMR (125 MHz, CDCl3) δ 208.5, 165.3, 
141.7, 135.7, 133.8, 119.9, 117.4, 50.6, 50.0, 45.4, 44.2, 33.3, 
32.7, 28.8, 24.7; IR (Neat Film NaCl) 3072, 2966, 2914, 1648, 
1625, 1448, 1378, 1225, 1122, 1079, 912 cm-1; HRMS m/z calc'd 
for C15H20O [M]+: 216.1514, found 216.1505; [α]D24.9 +12.59 (c 
1.165, CHCl3). 
4.10.  (1R,6R,8aS,Z)-6-allyl-1-hydroxy-6,8a-dimethyl-6,7,8,8a-
tetrahydroazulen-5(1H)-one (17) 
A flask was charged with (6R,8aR)-6-allyl-6,8a-dimethyl-
6,7,8,8a-tetrahydroazulen-5(1H)-one (2, 4.4093 g, 20.38 mmol) 
and 60 mL CH2Cl2. To the ice cooled mixture was added Et3N 
(12 mL, 86.10 mmol) followed by TBSOTf (9.5 mL, 41.36 
mmol) over 10 min. The reaction was stirred cold for 10 min and 
then allowed to warm to ambient temperature. After 3 hrs the 
reaction was cooled with an ice bath and 50 mL sat. NaHCO3 
was added. The mixture was extracted with hexane (3 x 50 mL) 
and the combined organic layers dried with Na2SO4. Evaporation 
in vacuo afforded a yellow residue that was dissolved in 100 mL 
95% EtOH and cooled with an ice bath. MMPP (12.6 g, 80%, 
20.38 mmol) was added in portions over 1 hour. After stirring a 
further 15 min the mixture was evaporated in vacuo to a volume 
of 20-30 mL. Water (100 mL) was added and the mixture 
extracted with CH2Cl2 (3 x 100 mL). The combined organic 
layers were dried with MgSO4 and evaporated in vacuo. Silica 
gel chromatography (3 cm x 18 cm, ~330 mL 5:1 Hex/EtOAc, 
then ~600 mL 3:1 Hex/EtOAc) afforded the title compound as a 
pale yellow oil (3.9786 g, 84% yield). RF = 0.10 (5:1 
Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 6.35 (dd, J = 2, 
5.5 Hz, 1H), 6.31 (d, J = 5 Hz, 1H), 5.83 (dddd, J = 7, 8, 11.5, 
11.5 Hz, 1H), 5.82 (s, 1H), 5.07-5.03 (m, 2H), 4.24 (d, J = 2.5 
Hz, 1H), 2.49 (dd, J = 6.5, 14 Hz, 1H), 2.29 (m, 1H), 2.20 (dd, J 
= 8, 14 Hz, 1H), 2.10 (m, 1H), 1.93 (br s, 1H), 1.64 (app ddd, J = 
2, 6.5, 6.5 Hz, 1H), 1.60 (app ddd, J = 2, 6, 6 Hz, 1H), 1.15 (s, 
3H), 1.08 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 208.1, 161.6, 
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141.1, 137.4, 135.4, 122.6, 117.6, 84.8, 49.7, 48.1, 43.8, 30.9, 
27.6, 27.1, 24.4; IR (Neat Film NaCl) 3401, 3073, 2963, 2915, 
1631, 1450, 1226, 1089, 1037, 915, 861 cm-1; HRMS m/z calc'd 
for C15H20O2 [M]+: 232.1463, found 232.1467; [α]D23.1 –64.33 (c 
1.49, CHCl3). 
4.11. (1R,6R,8aS)-6-Allyl-1-(tert-butyldimethylsilyloxy)-6,8a-
dimethyl-6,7,8,8a-tetrahydroazulen-5(1H)-one (18) 
A solution of (1R,6R,8aS,Z)-6-allyl-1-hydroxy-6,8a-dimethyl-
6,7,8,8a-tetrahydroazulen-5(1H)-one (17, 3.9786 g, 17.13 mmol) 
in 84 mL CH2Cl2 was cooled to –78 °C. To this mixture was 
added 2,6-lutidine (8 mL, 68.68 mmol, 4 equiv.), followed by 
TBSOTf (5.9 mL, 25.69 mmol, 1.5 equiv.) over ~5 min. The 
reaction was stirred cold for 45 min and then quenched by adding 
100 mL sat. NaHCO3. The mixture was allowed to thaw and the 
layers separated. The aqueous layer was washed with EtOAc (3 x 
100 mL) and the combined organic layers dried with MgSO4. 
Evaporation in vacuo, followed by silica gel chromatography (5 
cm x 15 cm, 35:1 pet. ether:EtOAc) afforded the title compound 
as a colorless oil (4.5484 g, 77% yield). RF = 0.17 (20:1 
Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 6.23 (d, J = 5.5 
Hz, 1H), 6.19 (dd, J = 2.5, 5 Hz, 1H), 5.84 (dddd, J = 7, 8, 12.5, 
12.5 Hz, 1H), 5.78 (s, 1H), 5.06-5.01 (m, 2H), 4.23 (d, J = 2.5 
Hz, 1H), 2.48 (dd, J = 7, 13.5 Hz, 1H), 2.31 (ddd, J = 2.5, 14.5, 
14.5 Hz, 1H), 2.20 (dd, J = 8, 14 Hz, 1H), 2.04 (ddd, J = 2, 15, 
15 Hz, 1H), 1.59 (ddd, J = 2, 5.5, 14.5 Hz, 1H), 1.46 (ddd, J = 2, 
5.5, 14.5 Hz, 1H), 1.15 (s, 3H), 1.06 (s, 3H), 0.90 (s, 9H), 0.09 (s, 
3H), 0.08 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 208.3, 162.4, 
141.6, 136.2, 135.6, 122.0, 117.4, 85.1, 49.7, 48.4, 43.8, 31.0, 
27.9, 27.6, 25.8, 24.4, 18.3, –4.3, –4.7; IR (Neat Film NaCl) 
3073, 2957, 2929, 1656, 1637, 1472, 1258, 1096, 1067, 872, 837, 
775 cm-1; HRMS m/z calc'd for C21H34O2Si [M]+: 346.2328, 
found 346.2326; [α]D23.1 –149.36 (c 1.56, CHCl3). 
4.12.  (6R,8aS)-6-Allyl-6,8a-dimethyl-6,7,8,8a-
tetrahydroazulene-1,5-dione (27) 
A vial was charged with a mixture of (1R,6R,8aS)-6-allyl-1-(tert-
butyldimethylsilyloxy)-6,8a-dimethyl-6,7,8,8a-tetrahydroazulen-
5(1H)-one and (6R,8aR)-6-allyl-6,8a-dimethyl-6,7,8,8a-
tetrahydroazulen-5(1H)-one (20.3 mg) and 0.3 mL THF. TBAF 
(1.0M in THF, 50 L, 0.050 mmol) was added and the mixture 
stirred 15 min. The volatiles were removed in vacuo and the 
residue taken up in EtOAc and filtered through a plug of silica 
gel, rinsing with EtOAc. Evaporation in vacuo gave a residue that 
was dissolved in 0.3 mL CH2Cl2. Dess–Martin periodinane (19.6 
mg, 0.0462 mmol) was added. After 40 min, isopropanol was 
added and the mixture evaporated in vacuo. Flash 
chromatography (0.7 cm x 7 cm, 10:1 Hex/EtOAc) afforded the 
title compound as a colorless oil (8 mg): RF = 0.11 (10:1 
Hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.69 (d, J = 5.7 
Hz, 1H), 6.37 (d, J = 5.4 Hz, 1H), 6.00 (s, 1H), 5.83 (dddd, J = 
7.2, 7.2, 10.5, 14.7 Hz, 1H), 5.12-5.02 (m, 2H), 2.40 (app dd, J = 
7.2, 14.1 Hz, 1H), 2.29 (app dd, J = 7.2, 13.5 Hz, 1H), 2.05 (ddd, 
J = 2.4, 14.7, 14.7 Hz, 1H), 1.92 (ddd, J = 3.3, 5.1, 14.7 Hz, 1H), 
1.77 (obsc ddd, J = 2.4, 18.3 Hz, 1H), 1.67 (ddd, J = 2.7, 5.1, 
14.7 Hz, 1H), 1.13 (s, 3H), 1.09 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 209.4, 207.8, 155.8, 152.8, 134.7, 134.1, 125.2, 118.2, 
50.8, 48.9, 43.3, 32.2, 26.8, 22.6, 22.0; IR (Neat Film NaCl) 
3071, 2973, 2932, 1713, 1675, 1550, 1448, 1379, 1345, 1227, 
1090, 1073, 917, 866, 627 cm-1; HRMS m/z calc'd for C15H18O2 
[M]+: 230.1307, found 230.1302; [α]D23.5 +46.28 (c 0.40, 
CH2Cl2). 
4.13. 3-((1R,6R,8aS,Z)-1-(tert-Butyldimethylsilyloxy)-6,8a-
dimethyl-5-oxo-1,5,6,7,8,8a-hexahydroazulen-6-yl)propanal (19) 
To a solution of (1R,6R,8aS)-6-allyl-1-(tert-
butyldimethylsilyloxy)-6,8a-dimethyl-6,7,8,8a-tetrahydroazulen-
5(1H)-one (18, 4.5484 g, 13.12 mmol) in 130 mL degassed 
CH2Cl2 was added 4,4,5,5-tetramethyl-2-vinyl-1,3,2-
dioxaborolane20 (10.3126 g, 66.96 mmol, 5 equiv.) followed by 
the second generation Hoveyda–Grubbs catalyst (412.5 mg, 
0.658 mmol, 5 mol%). The mixture was then heated to reflux for 
12 hrs at which time it was cooled and 10 mL ethyl vinyl ether 
was added. After stirring for 30 min at ambient temperature, the 
reaction mixture was then concentrated in vacuo. The residue 
was applied to the top of a 6.5 x 1.5 cm pad of silica gel and 
eluted with a total of 600 mL 10:1 Hex/EtOAc. The filtrate was 
evaporated in vacuo and the residue dissolved in 130 mL THF. 
Anhydrous Me3NO21 (5.03 g, 66.97 mmol) was added and the 
mixture heated to reflux for 10 hrs. To the cooled reaction 
mixture was added 50 mL H2O and the mixture was allowed to 
stir ~15 min. Brine (50 mL) was added and the layers separated. 
The organic layer was washed with 50 mL brine, and the 
combined aqueous layers washed with EtOAc (3 x 100 mL). The 
combined organic layers were dried with MgSO4 and 
concentrated in vacuo. Silica gel chromatography (5 x 15 cm, 
~600 mL 7:1 Hex/EtOAc then ~450 mL 6:1 Hex/EtOAc) 
afforded the title compound (3.7336 g, 78%) as a yellow oil. RF = 
0.3 (5:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 9.79 (dd, 
J = 1.5, 1.5 Hz, 1H), 6.22 (d, J = 5.5 Hz, 1H), 6.20 (dd, J = 2.5, 
5.5 Hz, 1H), 5.76 (s, 1H), 4.23 (d, J = 2.5 Hz, 1H), 2.53 (m, 1H), 
2.47 (m, 1H), 2.36 (ddd, J = 2, 14.5, 14.5 Hz, 1H), 2.10 (ddd, J = 
2.5, 14.5, 14.5 Hz, 1H), 2.02 (ddd, J = 6.5, 9.5, 14.5 Hz, 1H), 
1.72 (ddd, J = 6, 9.5, 14 Hz, 1H), 1.54 (ddd, J = 2, 6, 14.5 Hz, 
1H), 1.46 (ddd, J = 2, 5.5, 14.5 Hz, 1H), 1.17 (s, 3H), 1.06 (s, 
3H), 0.89 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 207.9, 202.7, 162.6, 141.9, 136.1, 121.8, 85.0, 
49.5, 48.3, 39.8, 31.6, 31.2, 27.8, 27.4, 25.8, 24.8, 18.2, –4.3,  
–4.8; IR (Neat Film NaCl) 3059, 2956, 2928, 1725, 1654, 1636, 
1472, 1451, 1382, 1361, 1250, 1095, 1062, 936, 870, 837, 775 
cm
-1; HRMS m/z calc'd for C21H34O3Si [M]+: 362.2277, found 
362.2260; [α]D23.3 –127.87 (c 2.305, CHCl3). 
4.14. Ethyl 5-((1R,6R,8aS,Z)-1-(tert-butyldimethylsilyloxy)-6,8a-
dimethyl-5-oxo-1,5,6,7,8,8a-hexahydroazulen-6-yl)-3-
oxopentanoate (20) 
A 250 mL round-bottom flask was charged with 3-
((1R,6R,8aS,Z)-1-(tert-butyldimethylsilyloxy)-6,8a-dimethyl-5-
oxo-1,5,6,7,8,8a-hexahydroazulen-6-yl)propanal (19, 3.7336 g, 
10.30 mmol) and 100 mL CH2Cl2. Anhydrous SnCl2 (195.4 mg, 
1.031 mmol) was added, followed by ethyl diazoacetate (1.1946 
g, 10.47 mmol) over ~ 5 min. The reaction was stirred 1.5 hrs at 
ambient temperature and a further portion of ethyl diazoacetate 
(210 L, 2.00 mmol) was added. After stirring another 1.5 hrs, 
the reaction was concentrated in vacuo, and the residue subjected 
to silica gel chromatography (3 cm x 31 cm, 7:1 Hex:EtOAc) to 
afford the title compound as a viscous yellow oil (4.0558 g, 88% 
yield). RF = 0.28 (5:1 Hexane:EtOAc); Major keto tautomer: 
1H NMR (500 MHz, CDCl3) δ 6.23 (d, J = 6 Hz, 1H), 6.20 (dd, J 
= 2.5, 5.5 Hz, 1H), 5.75 (s, 1H), 4.23 (d, J = 2.5 Hz, 1H), 4.19 
(app q, J = 7.5 Hz, 2H), 3.48 (s, 1.6H), 2.64 (m, 1H), 2.62 (m, 
1H), 2.36 (ddd, J = 2, 14.5, 14.5 Hz, 1H), 2.09 (ddd, J = 2, 14.5, 
14.5 Hz, 1H), 1.97 (ddd, J = 6.5, 8.5, 14 Hz, 1H), 1.71 (ddd, J = 
6, 9.5, 14 Hz, 1H), 1.54 (ddd, J = 2.5, 6, 15 Hz, 1H), 1.46 (ddd, J 
= 2, 6, 15 Hz, 1H), 1.27 (dd, J = 7, 7 Hz, 3H), 1.17 (s, 3H), 1.06 
(s, 3H), 0.89 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 208.0, 203.1, 167.4, 162.5, 141.9, 136.1, 121.9, 
85.0, 61.3, 49.5, 49.2, 48.3, 38.9, 33.1, 31.2, 27.8, 27.4, 25.8, 
24.8, 18.2, 14.1, –4.3, –4.7; IR (Neat Film NaCl) 3054, 2956, 
2929, 1744, 1718, 1653, 1636, 1472, 1449, 1367, 1318, 1258, 
1165, 1095, 1071, 936, 869, 837, 802, 775 cm-1; HRMS m/z 
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calc'd for C25H40O5Si [M]+: 448.2645, found 448.2631; [α]D23.4 –
122.05 (c 0.870, CHCl3). 
4.15. Knoevenagel cyclization (preparation of compound 21) 
To a solution of ethyl 5-((1R,6R,8aS,Z)-1-(tert-
butyldimethylsilyloxy)-6,8a-dimethyl-5-oxo-1,5,6,7,8,8a-
hexahydroazulen-6-yl)-3-oxopentanoate (20, 2.3213 g, 5.17 
mmol, 1 equiv) in 52 mL EtOH was added KF (337.9 mg, 0.280 
mmol, 1.1 equiv). The mixture was then heated to 80 °C for 10 
hrs, at which time TLC analysis (twice developed in 10:1 
Hex/EtOAc) indicated no SM was present. The reaction was then 
cooled and evaporated in vacuo. The residue was directly applied 
to a column of silica (3 x 22 cm) and eluted with 10:1 
Hex/EtOAc. Unclean fractions were chromatographed again (2 x 
18 cm silica gel) to afford compound 21 (1.6580 g, 74%) as a 
yellow oil that solidified on standing. RF = 0.29 (5:1 
Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 6.19 (d, J = 5.5 
Hz, 1H), 6.13 (dd, J = 2, 5 Hz, 1H), 6.00 (s, 1H), 4.30 (dq, J = 7, 
13.5 Hz, 1H), 4.23 (dq, J = 7, 13.5 Hz, 1H), 4.22 (obsc d, J = 3.5 
Hz, 1H), 2.64 (m, 1H), 2.62 (m, 1H), 2.27 (app br t, J = 13.5 Hz, 
1H), 2.10 (br s, 1H), 2.01 (m, 1H), 1.81 (ddd, J = 5.5, 5.5, 11 Hz, 
1H), 1.62 (ddd, J = 2, 7, 15 Hz, 1H), 1.37 (ddd, J = 2, 7, 15.5 Hz, 
1H), 1.27 (dd, J = 7, 7 Hz, 3H), 1.22 (s, 3H), 1.05 (s, 3H), 0.89 
(s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
195.2, 167.3, 162.1 (br), 161.4 (br), 140.1, 136.6, 132.6, 117.6 
(br), 85.2, 61.0, 48.2, 37.6 (br), 36.5, 33.6, 27.2, 27.1 (br), 25.8, 
25.8, 24.6 (br), 18.2, 14.1, –4.3, –4.7; IR (Neat Film NaCl) 3054, 
2955, 2928, 1734, 1671, 1617, 1472, 1451, 1367, 1321, 1229, 
1136, 1093, 1071, 1031, 872, 836, 774 cm-1; FAB+ HRMS m/z 
calc'd for C25H39O4Si [M+H]+: 431.2618, found 431.2614; 
[α]D23.4 –909.69 (c 1.945, CHCl3). 
4.16. Diastereoselective reduction of β-ketoester 21 
A solution of Knoevenagel product 21 (1.6173 g, 3.76 mmol) in 
40 mL isopropanol, was degassed by bubbling argon through the 
mixture for 30 min. Ru[(S,S)-Ts-DPEN](p-cymene) (112.9 mg, 
0.188 mmol, 5 mol%) was then added. The mixture was stirred at 
ambient temperature for 24 hrs and then evaporated in vacuo. 
After silica gel chromatography (3 x 24 cm, 7:1 Hex/EtOAc), any 
fractions containing unreacted starting material were pooled and 
collected away from the reaction product. This residue (461.8 
mg) containing ketoester 21 was then dissolved in 11 mL 
isopropanol and degassed as above. Ru[(S,S)-Ts-DPEN](p-
cymene) (7.2 mg, 0.0120 mmol) was then added. The mixture 
was stirred at ambient temperature for 36 hrs and then evaporated 
in vacuo. After silica gel chromatography (2 x 17 cm, 7:1 
Hex/EtOAc), any fractions containing unreacted starting material 
were pooled and subjected to one further silica gel column (2 x 
17 cm, 7:1 Hex/EtOAc). The final product (22) was isolated as a 
brown viscous oil (1.3934 g, 86%). RF = 0.26 (5:1 
Hexane:EtOAc); 1H NMR (500 MHz, CDCl3, 50 ºC) δ 6.21 (s, 
1H), 6.20 (d, J = 5.5 Hz, 1H), 5.95 (dd, J = 2.5, 5.5 Hz, 1H), 4.54 
(br d, J = 3.5 Hz, 1H), 4.24 (dq, J = 7, 13.5 Hz, 1H), 4.20 (obsc 
d, J = 2.5 Hz, 1H), 4.19 (dq, J = 7, 13.5 Hz, 1H), 2.59 (bs, 1H), 
2.12 (app t, J = 13 Hz, 1H), 1.95-1.85 (m, 4 H), 1.58 (ddd, J = 2, 
7.5, 14.5 Hz, 1H), 1.39-1.37 (obsc m, 1H), 1.33 (ddd, J = 2, 7.5, 
15 Hz, 1H), 1.27 (dd, J = 7, 7 Hz, 3H), 1.05 (s, 3H), 1.00 (s, 3H), 
0.90 (s, 9H), 0.082 (s, 3H), 0.076 (s, 3H); IR (Neat Film NaCl) 
3435, 3054, 2951, 2929, 1700, 1472, 1366, 1257, 1216, 1089, 
1073, 873, 835, 773 cm-1; HRMS m/z calc'd for C25H40O4Si [M]+: 
432.2696, found 432.2716; [α]D23.4 –707.61 (c 0.620, CHCl3). 
Note: due to conformational instability, we were unable to obtain 
a suitable 13C NMR spectrum. 
4.17. Conversion to acetonide 23 
Ester 22 (1.3934 g, 3.22 mmol) was dissolved in 30 mL THF and 
cooled to 0 °C. Red-Al (~3.5 M solution in toluene, 3.6 mL, 12.6 
mmol) was added slowly over 5 min. The mixture was allowed to 
stir cold for 1 hr. The reaction was quenched by the careful 
addition of EtOH (15 mL). The mixture was then warmed to 
ambient temperature and Na2SO4•10 H2O (15 g) was added. After 
stirring vigorously for 1 hour, the mixture was filtered through a 
fritted glass funnel and the salts rinsed with EtOAc(3 x 50 mL). 
Evaporation in vacuo gave a residue that was subjected to flash 
chromatography (3 x 18 cm, 2:1 Hex/EtOAc) to afford a diol 
product (960.2 mg, 76% yield). RF = 0.16 (2:1 Hexane:EtOAc); 
1H NMR (300 MHz, CDCl3) δ 6.18 (d, J = 5.4 Hz, 1H), 5.95 (s, 
1H), 5.92 (dd, J = 2.1, 5.4 Hz, 1H), 4.40-4.32 (m, 2H), 4.28-4.20 
(m, 2H), 2.40 (bs, 1H), 2.15-1.65 (m, 5H), 1.60 (bs, 1H), 1.55-
1.22 (m, 3H), 0.99 (s, 3H), 0.97 (s, 3H), 0.89 (s, 9H), 0.07 (s, 
6H); IR (Neat Film NaCl) 3352, 3054, 2953, 2929, 1650, 1472, 
1463, 1450, 1362, 1256, 1092, 1059, 1005, 870, 836, 774 cm-1; 
FAB+ HRMS m/z calc'd for C23H37O3Si [(M+H)-H2]+: 389.2512, 
found 389.2509. Note: due to conformational instability, we 
were unable to obtain a suitable 13C NMR spectrum. 
The isolated diol was dissolved in 25 mL CH2Cl2 and cooled 
to 0 °C. PPTS (30.3 mg, 0.121 mmol, 5 mol%) was added, 
followed by 2,2-dimethoxypropane (6 mL, 48.80 mmol, 20 
equiv). After stirring cold for 1 hour, the reaction mixture was 
evaporated in vacuo and the residue subjected to flash 
chromatography (3 x 25 cm, 25:1 Hex/EtOAc) to afford 
acetonide 23 (552.8 mg, 52% yield) as a white solid. RF = 0.32 
(20:1 Hexane:EtOAc); 1H NMR (500 MHz, CDCl3) δ 6.15 (d, J = 
5.5 Hz, 1H), 5.88 (dd, J = 2.5, 5.5 Hz, 1H), 5.69 (s, 1H), 4.35 
(dddd, J = 1.5, 3.5, 3.5, 7.5 Hz, 1H), 4.29 (d, J = 15.5 Hz, 1H), 
4.26 (d, J = 2.5 Hz, 1H), 4.13 (ddd, J = 2, 2, 16 Hz, 1H), 2.24 
(ddd, J = 3, 14.5, 14.5 Hz, 1H), 2.00 (ddd, J = 3, 14, 14 Hz, 1H), 
1.84 (dddd, J = 3.5, 3.5, 7, 12.5 Hz, 1H), 1.71 (dddd, J = 6, 10.5, 
10.5, 10.5 Hz, 1H), 1.60-1.52 (m, 2H), 1.43 (s, 3H), 1.38 (obsc 
ddd, J = 3, 4.5, 13.5 Hz, 1H), 1.35 (s, 3H), 1.29 (ddd, J = 3, 5, 15 
Hz, 1H), 0.97 (s, 3H), 0.96 (s, 3H), 0.89 (s, 9H), 0.07 (s, 6H); 13C 
NMR (125 MHz, CDCl3) δ 153.5, 135.6, 135.5, 134.9, 133.1, 
117.8, 99.5, 86.4, 67.8, 60.5, 46.7, 38.6, 36.9, 36.0, 26.9, 25.9, 
25.9, 25.3, 25.0, 24.4, 23.8, 18.3, –4.4, –4.7; IR (Neat Film NaCl) 
3054, 2951, 2930, 1472, 1378, 1250, 1224, 1092, 1064, 866, 835, 
774 cm-1; FAB+ HRMS m/z calc'd for C26H41O3Si [(M+H)-H2]+: 
429.2825, found 429.2805; [α]D24.9 –514.23 (c 1.54, CHCl3). 
4.18. Conversion to pivalate 24 
Compound 23 (30.5 mg, 0.708 mmol) was dissolved in 0.2 mL 
THF and TBAF (1.0 M in THF, 150 L, 0.150 mmol) was added 
at ambient temperature. The reaction was allowed to stir at 
ambient temperature 2.5 hrs at which time it was filtered through 
a plug of silica gel, eluted with EtOAc, and evaporated in vacuo. 
The residue was then dissolved in 0.3 mL pyridine and 
trimethylacetyl chloride (50 L, 0.406 mmol) was added. The 
mixture was then heated to 50 ºC for 30 min. The cooled reaction 
mixture was then applied to a column of silica (3 x 2 cm) and 
eluted with 20:1 Hex/EtOAc to afford pivalate ester 24 (24.7 mg, 
87%) as a white solid. RF = 0.33 (10:1 Hexane:EtOAc); 1H NMR 
(500 MHz, CDCl3) δ 6.29 (d, J = 6 Hz, 1H), 5.90 (dd, J = 2.5, 5 
Hz, 1H), 5.77 (s, 1H), 5.33 (d, J = 2.5 Hz, 1H), 4.35 (ddd, J = 1, 
5.5, 9 Hz, 1H), 4.29 (d, J = 15.5 Hz, 1H), 4.13 (ddd, J = 2, 2, 16 
Hz, 1H), 2.24 (ddd, J = 2.5, 13.5, 13.5 Hz, 1H), 1.95 (ddd, J = 3, 
14, 14 Hz, 1H), 1.85 (dddd, J = 3.5, 3.5, 6.5, 13 Hz, 1H), 1.70 
(m, 1H), 1.6-1.55 (m, 2H), 1.43 (s, 3H), 1.39-1.23 (m, 2H), 1.35 
(s, 3H), 1.19 (s, 9H), 1.08 (s, 3H), 0.98 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 178.2, 152.6, 138.5, 134.2, 134.1, 131.4, 118.8, 
99.7, 86.8, 67.7, 60.4, 46.2, 39.0, 38.5, 36.7, 36.0, 27.2, 26.8, 
26.1, 25.2, 24.9, 23.9, 23.8; IR (Neat Film NaCl) 3049, 2980, 
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2938, 1724, 1455, 1379, 1279, 1224, 1152, 1093, 1028, 976, 865 
cm
-1; HRMS m/z calc'd for C25H36O4 [M]+: 400.2614, found 
400.2610; [α]D23.7 –533.13 (c 1.185, CHCl3). 
4.19. Conversion to cyclopentanone 25 
Compound 23 (262 mg, 0.608 mmol) was dissolved in 5 mL 
THF and cooled with an ice bath. TBAF (1.0M in THF, 2.4 mL, 
2.4 mmol) was added dropwise and the ice bath was removed. 
After stirring at ambient temperature for 2 hours, the volatiles 
were evaporated in vacuo to leave a viscous orange residue 
which was applied to a 3 x 2 cm plug of silica gel and eluted with 
3:1 Hex/EtOAc (~350 mL total). Evaporation in vacuo provided 
a residue that was dissolved in 3 mL EtOAc and cooled with an 
ice bath. Pd/C was added (5 wt% Pd, 65.4 mg, 0.0307 mmol Pd, 
5 mol%). The atmosphere was evacuated three times, filling with 
H2 (balloon) each time. The reaction was stirred at 0 °C for 2.5 
hours, with monitoring by TLC (AgNO3 treated silica plates, 5:1 
Hex/EtOAc). Once complete, the reaction was filtered through a 
3 x 1 cm plug of silica gel and rinsed with ~65 mL EtOAc. 
Evaporation in vacuo afforded a residue that was dissolved in 3 
mL CH2Cl2. To the solution was added 413.2 mg 4Å molecular 
sieves, NMO (110.8 mg, 0.946 mg, 1.5 equiv), and then TPAP 
(10.6 mg, 0.0302 mmol, 5 mol%). The reaction was allowed to 
stir 40 min and was then filtered through a 3 x 1 cm plug of silica 
gel which was rinsed with ~50 mL EtOAc. Evaporation in vacuo, 
followed by silica gel chromatography (2 x 12 cm, 10% Et2O in 
petroleum ether) afforded cyclopentatnone 25 (174 mg, 90% over 
three steps) as a viscous colorless oil. RF = 0.16 (10:1 
Hexane:EtOAc), 0.36 (5:1 Hex:EtOAc); 1H NMR (500 MHz, 
CDCl3) δ 5.78 (s, 1H), 4.40-4.30 (m, 1H), 4.27 (d, J = 15 Hz, 
1H), 4.14 (ddd, J = 2, 2, 15 Hz, 1H), 2.71-2.58 (m, 2H), 2.52 
(ddd, J = 4.5, 9.5, 18 Hz, 1H), 2.42 (ddd, J = 10, 10, 18 Hz, 1H), 
2.24 (ddd, J = 2.5, 13.5, 13.5 Hz, 1H), 1.89-1.83 (m, 1H), 1.74-
1.66 (m, 2H), 1.61 (ddd, J = 3.5, 5, 14 Hz, 1 H), 1.57-1.50 (m, 
2H), 1.43 (s, 3H), 1.39-1.34 (obsc m, 1H), 1.36 (s, 3H), 1.07 (s, 
3H), 0.98 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 222.2, 146.3, 
133.8, 132.4, 120.5, 99.5, 67.4, 60.5, 51.5, 37.9, 36.7, 36.7, 36.1, 
28.4, 26.9, 26.5, 25.3, 25.2, 23.5, 20.0; IR (Neat Film NaCl) 
2982, 2937, 1743, 1445, 1378, 1224, 1090, 1026, 863 cm-1; 
HRMS m/z calc'd for C20H28O3 [M]+: 316.2039, found 316.2030; 
[α]D25.2 –91.95 (c 0.695, CHCl3). 
4.20. Installation of isopropyl (preparation of compound 26) 
A solution of ketone 25 (42.9 mg, 0.136 mmol, evaporated twice 
from benzene) dissolved in 0.5 mL THF and cooled to –78 °C 
was added via teflon cannula to a solution of KHMDS (37.2 mg, 
0.186 mmol) in 0.6 mL THF at –78 °C with a 0.5 mL rinse. The 
mixture was stirred 30 min and then added, via Teflon cannula, 
to a solution of PhNTf2 (70 mg, 0.196 mmol, evaporated twice 
from benzene) in 1 mL THF at –78 °C. After 50 min, silica gel 
was added and the suspension allowed to warm to ambient 
temperature. After evaporation in vacuo, the solid mixture was 
subjected to flash chromatography (2 x 12 cm, 5% Et2O in 
petroleum ether) to afford a vinyl triflate (36 mg, 59% yield) as a 
colorless oil. RF = 0.2 (20:1 Hexane:EtOAc); 1H NMR (300 
MHz, C6D6) δ 5.33 (bs, 1H), 5.22 (dd, J = 2.4, 2.4 Hz, 1H), 4.31-
4.21 (m, 1H), 4.18-4.06 (m, 2H), 2.59 (ddd, J = 2.4, 2.4, 20.7 Hz, 
1H), 2.49 (ddd, 2.4, 2.4, 20.7 Hz, 1H), 1.96 (ddd, J = 3.3. 13.8, 
13.8 Hz, 1H), 1.80-1.68 (m, 2H), 1.62 (ddd, J = 3, 13.8, 13.8 Hz, 
1H), 1.45-1.12 (m, XH), 1.40 (s, 3H), 1.36 (s, 3H), 1.05 (s, 3H), 
0.96 (ddd, J = 3, 4.2, 14.4 Hz, 1H), 0.81 (s, 3H). 
The vinyl triflate prepared above was evaporated twice from 
benzene. CuI (1.8 mg, 0.00945 mg, 12 mol%) and THF (0.65 
mL) were added under an atmosphere of argon and the 
suspension cooled to –15 °C. i-PrMgCl (1.91 M in THF, 0.13 
mL, 0.248 mmol, 3.1 equiv) was added quickly and the reaction 
turned from blue to green to yellow brown. The reaction mixture 
was kept between –20 and –15 °C for 2.5 hrs and then warmed 
with an ice bath and silica gel added. After evaporation in vacuo, 
the solid mixture was subjected to flash chromatography (3 x 2 
cm, 5% Et2O in petroleum ether) to afford compound 26 (23.5 
mg, 85%, contaminated with ~10% reduction product) as a 
colorless oil. RF = 0.43 (20:1 Hexane:EtOAc); 1H NMR (300 
MHz, CDCl3) δ 5.62 (bs, 1H), 5.37 (dd, J = 2.4, 2.4 Hz, 1H), 
4.39-4.31 (m, 1H), 4.26 (d, J = 15 Hz, 1H), 4.16 (ddd, J = 1.5, 
1.5, 15 Hz, 1H), 2.59 (ddd, J = 2.1, 2.1, 21.6 Hz, 1H), 2.49 (ddd, 
2,1, 2.1, 21 Hz, 1H), 2.28 (ddd, J = 3.3, 13.2, 13.2 Hz, 1H), 2.14 
(app pent, J = 6.9 Hz, 1H), 1.90-1.79 (m, 1H), 1.79-1.57 (m, 3H), 
1.57-1.50 (m, 2H), 1.44 (s, 3H), 1.37 (s, 3H), 1.09 (s, 3H), 1.06 
(d, J = 6.6 Hz, 3H), 1.04 (d, J = 6.6 Hz, 3H), 0.99 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 159.4, 150.9, 134.9, 130.9, 117.9, 
117.6, 99.4, 67.7, 60.5, 52.8, 38.3, 37.8, 37.3, 35.9, 30.6, 26.8, 
25.5, 25.4, 25.3, 25.0, 24.9, 23.6, 21.4; IR (Neat Film NaCl) 
3044, 2956, 2935, 1651, 1455, 1377, 1223, 1091, 863, 755 cm-1; 
HRMS m/z calc'd for C23H33O2 [(M+H)-H2]+: 341.2481, found 
341.2489; [α]D24.4 –169.01 (c 0.075, CHCl3). 
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